Medtronic Purchases Innovative Gel Technology for Potential Use in Functional Endoscopic Sinus Surgery

Medtronic, Inc. MDT today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research & Innovation Pty Ltd. in Australia, Robinson Squidgel Ltd., and Otago Innovation Ltd. in New Zealand. Medtronic is acquiring this technology for potential use in developing future products for functional endoscopic sinus surgery.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!